NASDAQ:XTLB

XTL Biopharmaceuticals Ltd. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$2.59

+0.170 (+7.02%)

At Close: Apr 30, 2024

Currently predicting for Wed, 1 May 2024

Trading levels for XTLB

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	2.66	2.83 %
		R2	2.63	1.36 %
		R1	2.60	0.445 %
Current price:			2.59
	Support	S1	2.53	-2.50 %
		S2	2.50	-3.42 %
		S3	2.46	-4.89 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	3.07	18.53 %
		R2	2.81	8.49 %
		R1	2.62	1.16 %
Current price			2.59
	Support	S1	2.47	-4.63%
		S2	2.42	-6.56%
		S3	2.38	-8.11%

XTLB Predictions History

3 years ago
JS predicted that XTLB for 2020-12-21 is going $2.85 (0.71%)

3 years ago
JS predicted that XTLB for 2020-12-18 is going $2.89 (0.35%)

3 years ago
JS predicted that XTLB for 2020-12-11 is going $2.49 (4.18%)

4 years ago
NameNotImportant predicted that XTLB for 2019-05-06 is going $2.28 (-1.72%)

About XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD... XTLB Profile

Golden Star

Ticker	Date	Change	Price
DHT	Apr 24	1.95%	$11.28
MLI	Apr 19	11.07%	$52.28
LPLA	Apr 19	4.31%	$262.59
DOOR	Apr 18	0.90%	$131.39
PFLT	Apr 18	1.78%	$11.25
LNG	Apr 17	3.12%	$156.81
FCN	Apr 16	2.83%	$207.62
ELV	Apr 16	5.33%	$506.97
AKR	Apr 05	6.47%	$16.53
ITCI	Apr 05	5.64%	$68.44

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In